SCHEMBL20596077

SCHEMBL20596077

COc1ccc(-c2ccc(N)c3nc(CC(=O)O)cn23)c(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 1/20 0.39
▸ HSP90AB1 P08238 1/20 0.39
▸ PTGS1 P23219 3/20 0.38
▸ AKR1C3 P42330 3/20 0.38
▸ AKR1C2 P52895 3/20 0.38
▸ CDC7 O00311 2/20 0.36
▸ DBF4 Q9UBU7 2/20 0.36
▸ CCNT1 O60563 1/20 0.36
▸ CSNK2A2 P19784 1/20 0.36
▸ CCNE1 P24864 1/20 0.36
▸ CDK2 P24941 1/20 0.36
▸ CSNK1A1 P48729 1/20 0.36
▸ CSNK1D P48730 1/20 0.36
▸ CDK9 P50750 1/20 0.36
▸ CSNK2B P67870 1/20 0.36
▸ CSNK2A1 P68400 1/20 0.36
▸ EIF4E P06730 1/20 0.36
▸ CRHR1 P34998 3/20 0.36
▸ KDM4E B2RXH2 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23419543 0.84 LMNA (0.36) HSP90AA1HSP90AB1PTGS1AKR1C3AKR1C2
SCHEMBL20595835 0.84 MEN1 (0.38) HSP90AA1HSP90AB1ALDH1A1SCN10AMEN1
SCHEMBL20595912 0.83 MAP2K4 (0.38) HSP90AA1HSP90AB1PTGS1AKR1C3AKR1C2
SCHEMBL20596625 0.81 ABL1 (0.37) HSP90AA1KDM4EALDH1A1MEN1LMNA
SCHEMBL30145306 0.81 ABL1 (0.37) HSP90AA1KDM4EALDH1A1MEN1LMNA
SCHEMBL30145317 0.81 MARS2 (0.44) PTGS1AKR1C3AKR1C2EIF4ECRHR1
SCHEMBL20595852 0.78 CYP11B1 (0.41) PTGS1AKR1C3AKR1C2CDC7DBF4
SCHEMBL20596538 0.76 LMNA (0.38) HSP90AA1HSP90AB1KDM4EALDH1A1HPGD
SCHEMBL20595968 0.75 AMY1A (0.43) ALDH1A1HPGDPOLBMEN1LMNA
SCHEMBL20596612 0.75 MARS2 (0.57) HSP90AA1HSP90AB1CRHR1NOS2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11584744-B2 Inhibitors of type 1 methionyl-tRNA synthetase and methods of using them UNIVERSITY OF WASHINGTON (US) 2023-02-21 — — US disclosed
US-11584744-B2 Inhibitors of type 1 methionyl-tRNA synthetase and methods of using them UNIVERSITY OF WASHINGTON (US) 2023-02-21 — — US disclosed
US-20210155617-A1 INHIBITORS OF TYPE l METHIONYL-TRNA SYNTHETASE AND METHODS OF USING THEM UNIVERSITY OF WASHINGTON 2021-05-27 — — US disclosed
US-20210155617-A1 INHIBITORS OF TYPE l METHIONYL-TRNA SYNTHETASE AND METHODS OF USING THEM UNIVERSITY OF WASHINGTON 2021-05-27 — — US disclosed
WO-2018237349-A1 INHIBITORS OF TYPED 1 METHIONYL-TRNA SYNTHETASE AND METHODS OF USING THEM UNIVERSITY OF WASHINGTON (US) 2018-12-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11584744-B2 Inhibitors of type 1 methionyl-tRNA synthetase and methods of using them AARS1, EMG1, GARS1 HSP90AA1 887/4885HSP90AB1 958/4885PTGS1 1206/4885
US-20210155617-A1 INHIBITORS OF TYPE l METHIONYL-TRNA SYNTHETASE AND METHODS OF USING THEM AARS1, GARS1, MTR HSP90AA1 1230/4885HSP90AB1 1339/4885PTGS1 1881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback